Submitted by: Submitted by girmarco
Views: 10
Words: 432
Pages: 2
Category: Business and Industry
Date Submitted: 10/27/2016 03:32 AM
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
Published by: GIR (GlobalInfoResearch)
Catalog: Biotechnology
Publishing Date: Oct 2016
Single User License: USD 3480
Corporate Users License: USD 4680
Delivery time: 24 hours
Pages: 114
Tables and Figures: 134
Full information :[url]http://www.globalinforesearch.com/goods.php?id=1253[url]
Scope of the Report:
This report focuses on the Insulin Glargine in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi-Aventis
Ganlee
Biocon
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
Latin America, Middle East and Africa
Market Segment by Type, covers
Single Dose Vial
Pre-filled Syringe
Market Segment by Applications, can be divided into
Treat type 1 diabetes
Treat type 2 diabetes
There are 13 Chapters to deeply display the global Insulin Glargine market.
Chapter 1, to describe Insulin Glargine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Insulin Glargine, with sales, revenue, and price of Insulin Glargine, in 2015 and 2016;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;
Chapter 4, to show...